Abstract: Various device attributes associated with a current event may be obtained. Similarity metrics may be determined that indicate a degree of similarity between the device attributes that are associated with the current event and stored device attributes that are associated with previous events and previously created fuzzy device identifiers. A fuzzy device identifier may be assigned to the current event based at least in part on a comparison of the similarity metrics with a threshold. If none of the similarity metrics compare favorably with the threshold, then a new fuzzy device identifier may be created for the current event. However, if at least one of the similarity metrics compares favorably with the threshold, then the previously created fuzzy device identifier whose stored device attributes are most similar to the device attributes that are associated with the current event may be assigned to the current event.

Abstract: Systems and methods for indexing and searching health data are disclosed herein. In some embodiments, a method for querying patient records includes receiving a search input that specifies a plurality of events, one or more temporal relationships between the events, and inclusion and/or exclusion criteria. An index query is constructed based at least in part on the plurality of events within the search input. The index query is then executed against an inverted index to identify matching patient records. One or more temporal constraints can be solved against the identified patient records. Finally, patient records satisfying the constraint(s) are returned.

Abstract: Various device attributes associated with a current event may be obtained. Similarity metrics may be determined that indicate a degree of similarity between the device attributes that are associated with the current event and stored device attributes that are associated with previous events and previously created fuzzy device identifiers. A fuzzy device identifier may be assigned to the current event based at least in part on a comparison of the similarity metrics with a threshold. If none of the similarity metrics compare favorably with the threshold, then a new fuzzy device identifier may be created for the current event. However, if at least one of the similarity metrics compares favorably with the threshold, then the previously created fuzzy device identifier whose stored device attributes are most similar to the device attributes that are associated with the current event may be assigned to the current event.

Abstract: Devices, systems, and methods for treating the pancreas are disclosed herein. For example, some aspects of the technology are directed to a method for treating a medical condition affecting the pancreas of a human patient, wherein the method comprises implanting an occlusive device within the pancreatic duct to induce atrophy of pancreatic tissue.

Abstract: Various device attributes associated with a current event may be obtained. Similarity metrics may be determined that indicate a degree of similarity between the device attributes that are associated with the current event and stored device attributes that are associated with previous events and previously created fuzzy device identifiers. A fuzzy device identifier may be assigned to the current event based at least in part on a comparison of the similarity metrics with a threshold. If none of the similarity metrics compare favorably with the threshold, then a new fuzzy device identifier may be created for the current event. However, if at least one of the similarity metrics compares favorably with the threshold, then the previously created fuzzy device identifier whose stored device attributes are most similar to the device attributes that are associated with the current event may be assigned to the current event.

Abstract: The present invention provides pharmaceutical suspensions of D-methionine in which the aqueous solubility of D-methionine is exceeded, thereby allowing oral administration of higher doses. The present invention also provides processes for preparing these suspensions. The present invention further provides methods for preventing, treating, or ameliorating oral mucositis, hearing loss due to chemotherapy, antibiotics and noise, neuronal damage due to various CNS disorders and injuries, and anthracycline toxicity.

Abstract: Certain tetraarylethylenes reverse drug resistance in multi-drug resistant tumors. These compounds apparently function by inhibiting a p-glycoprotein pump which becomes activated in late stage tumor development and which is inherently present in tumors from certain origins.